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Summanr This study u-as aimed at determining whether tumour DNA content measured bv cell image
analysis could proVide additional prognostic information when compared to that proVided bv flow cytometry.
Sections cut from paraffin blocks of tumours from 101 patients with node negative breast cancer were analysed
by both methods and the results related to other prognostic variables and to patient relapse and oserall
survisval. DNA ploidy measured by flow cytometry classified 46 tumours as diploid and 55 as aneuploid.
whereas bv cell image analysis 30 were diploid and 71 aneuploid (P<0.002). There were 20 tumours With
discrepancies betu-een the two methods: 18 of these were tumours with onlv one peak in flou- analysis. but
determined to be aneuploid with image analysis. DNA content as measured by both methods was significant
for predicting relapse and surviv-al by log-rank test. as were tumour histological grade. c-erbB-2 expression and
tumour size. Multivariate analysis showed DNA ploidy measured by flow cytometry to be the only variable of
independent significance (P<0.02) for both relapse and overall survival. Compared with cell image analysis.
flow cyvtometry demonstrated a significantly higher proportion of diploid tumours. which may be related to
differences in the internal standards applied to each method. We suggest that cell image analysis techniques
can provide more sensitive information on the DNA content of tumour cells by direct measurement of nuclear
DNA density of both normal lymphocytes and tumour cells in the same section. However, although image
analysis appears to be more sensitive than flow cytometry in detecting DNA aneuploidy. the image technique
appears to lack the specificity of flow cytometry in correlation with clinical outcome.
The traditional assessment of prognosis for patients with
breast cancer is whether the axillary lymph nodes are involv-
ed. with malignant cells at the time of surgery. Node positive
patients have a poor prognosis when compared to node
negative patients. However. patients with node negative
breast cancer do not all remain free of disease at 10 vears
and up to 30% will get recurrence. Recent research has
concentrated on identifying patients within this group who
are at risk of recurrence and may therefore benefit from
adjuvant therapy (Glick. 1988). Patients proven to have a
good prognosis may then be spared the adjuvant treatment
which has recently been suggested for all patients with breast
cancer irrespective of node status (Clinical Alert. NIH 1988).
Abnormal DNA content in several human tumours is an
important marker for biological activity and prognosis: its
role as a predictor of clinical outcome in women with
primary breast cancer has been evaluated in many studies
(Del Bino et al., 1989; Kallioniemi et al., 1988: Cornelisse et
al.. 1987). Few have focused on node negative disease and
the results of these are conflicting (Clark et al.. 1989: Muss et
al.. 1989: Yuan et al.. 1991). To assess the correlation
between tumour DNA content and clinical outcome with
long term follow-up, fixed archival materials are generally
used for flow cytometry. Unfortunately, with fixed tissue no
external standard can be used for DNA measurement (unlike
fresh tissue), and the criterion for classifying the DNA histo-
gram into diploid or aneuploid varies from one study to
another. More recently, some reports have suggested that cell
image analysis could provide more objective information
than flow cytometnrc analysis of DNA ploidy (Bauer et al,
1990; McFadden et al. 1990). However, a companrson
between the two methods in relation to disease prognosis has
not been performed.
The aim of this study was to measure DNA ploidy by both
flow cytometry analysis and cell image analysis using paraf-
fin-embedded tumour tissues from 101 patients with node
negative breast cancer with a minimum of 10 years follow-
up. These assays would then allow a comparison of the
results for the two methods and a correlation of DNA ploidy
measured by each method with disease outcome and patient
survival.
Materials and methods
Patients
One hundred and one patients presenting with node negative
primary breast cancer at the Royal Victoria Infirmary. New-
castle upon Tyne between 1978 and 1980 were studied. All
patients had axillary sampling to confirm the absence of
lymph node metastasis. Full clinical details were obtained.
with a minimum of 10 years follow-up. None of the patients
received radiotherapy prior to surgery and none of the
patients studied received adjuvant chemotherapy to the end
points of follow-up. which were time to relapse or death. The
details of the clinical variables relating to these patients are
listed in Table I. Primary tumour size was classified into
Table I Patient characteristics (n = 101)
Age (years) Median 54
Range 35-85
Menopausal status Premenopausal 32 (320o%)
Postmenopausal 69 (68%)
Histological grade Grade I + 2 49 (52°o)
Grade 3 45 (4800)
Unknown 7
c-erbB-2 expression Negative 70 (74%0)
Positive 24 (26%0)
Unknown 7
Tumour size T, ( < 2 cm) 53 (5500)
T2(> 2 cm) 43 (450°'0)
Unknown 5
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2 cm (TI) or >2 cm (T.) stages according to the original
pathology reports.
Histological grade and c-erbB-2 expression
Histological grading of the tumours was performed by an
experienced histologist without prior knowledge of DNA
ploidy and follow-up. Tumours were classified according to
Elston's modification of the Bloom and Richardson grading
(Elston. 1987). grade 1 being well differentiated. grade 2
moderately differentiated and grade 3 poorly differentiated.
Immunohistochemical staining for the c-erbB-2 oncoprotein
was carried out by an indirect immunoperoxidase technique
using the novel monoclonal antibody NCL-CB 11 (Novocastra
Laboratories. Newcastle upon Tyne) (Corbett et al.. 1990).
Tumours were scored according to intensity of membrane
staining as either c-erbB-2 negative or positive.
DNAfloe c!vtometrv
Paraffin-embedded tumour tissues were processed for DNA
flow cytometry after the method of Hedley et al. (1983).
Briefly, 40 jim sections (from the same blocks used for the
slides for image analysis) were cut for DNA analysis and one
or more adjacent 5 jim control sections were cut for evalua-
tion of c-erbB-2 expression and histological grade. Sections
were dewaxed. rehydrated through a series of ethanol solu-
tions into water and treated with 1% pepsin pH 2 (Sigma
P7012. Poole. Dorset). After filtration through a 35 jLm nylon
mesh. the nuclei were treated with 0.5 mg ml- RNAase
(Sizma R-5503. Poole. Dorset). and then stained with 50 jig
ml-' propidium iodide (Fluka 81845. Glossop. Derbyshire).
The DNA analysis was performed on a Becton Dickinson
FACS 420 flow cvtometer (San Jose. California). The 488 nm
line of an argon laser run at 400 mW was used for fluor-
scence excitation. A 585 ± 42 nm band-pass filter and a linear
amplifier were used to detect propidium iodide fluorescence.
Ten thousand events for each sample were stored and analys-
ed with Consort 30 software. Fresh human lymphocytes and
fixed benign breast tissue sections were used as controls to
standardise the fluorescence intensity scale. As the staining
intensity of fixed nuclei varied from one sample to another.
no external standard was included. The peak with lowest
fluorescence intensity in the DNA histogram was regarded as
representing the diploid cells. In most of the samples. fibro-
blasts. lymphocytes, and normal epithelial cells are included
in this peak and can be regarded as an internal standard.
Samples were classified as DNA-aneuploid if they contained
more than one peak (any second peak at or near the tetra-
ploid position was considered to indicate DNA aneuploidy
only if it contained more than 10% of the total number of
nuclei). All other samples were classified as diploid. Samples
with a CV of the diploid peak > 10% were considered
uninterpretable and excluded. DNA histograms were analys-
ed without any information of patient clinical variables and
follow-up.
to different cell populations for further processing analysis.
The IND of tumour cells in a sample were grouped accord-
ing to whether they clustered around the modal value (>0.5
and < 1.5 times the tumour cell modal IND) or whether
their IND was > 1.8 times the modal value. A tumour was
considered aneuploid by image analysis if the geometric mean
of the cells clustered around the modal value was > 1.5
times that of the lymphocytes in the same sample: or if the
tumour cells with high IND were more than 10% of the total
number of tumour cells measured. This method of classifica-
tion was felt to parallel the classification system used for the
flow cytometry results (Figures 1 and 2).
Statistical anal!sis
Possible correlations between the results of DNA analysis
and menopausal status. tumour size. histological grade. nodal
status and c-erbB-2 expression were examined using the Chi-
squared test. with Yeats correction. Univariate analysis. by
the log-rank test. was used to assess the influence of ploid'
on disease free survival and overall survival. and a multi-
variate analysis using Cox regression model was performed.
Results
In order to define a normal range for tissue section on image
analysis normal ductal cells were examined. For 38 slides in
which the ductal cells were measured as controls. the ratio of
geometric mean of the normal ductal cells (clustered between
0.5 and 1.5 times the modal IND) to that of the lymphocytes
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Fgure I An example of the integrated nuclear densit; (IND) distn-
bution for lymphocytes within a section cut from a breast tumour.
40-
Cell image analysis
Integrated nuclear density (IND) and nuclear area were
measured directly on the original diagnostic slides (Haema-
toxilin and Eosin stained) cut from the paraffin blocks for
these patients. using a Joyce-Loebl Magiscan MD with the
General Image Analysis Software (GENIAS). On each slide,
the IND and the nuclear area of at least 50 lymphocytes and
100 tumour cells were measured from several fields at
x 1.600 magnification. In 38 slides, the IND of the normal
breast ductal cells were also measured to provide a control
for further tumour DNA analysis. In all samples, the nuclear
area and the IND of each cell population had significant
positive correlation on regression analysis (r>0.9). To avoid
artifactual differences caused by the selection of cells, all the
cells in the field were measured except those which were
overlapping or doublets. The data from each field were
stored in separate computer files and merged again according
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Fiue 2 An example of the [ND distribution of tumour cells from
a section cut from a breast tumour.
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in the same section ranged from 1.0 to 1.49 (mean 1.38). The
reason the ductal cells had higher IND than lymphocytes
may be due to the size and shape of nuclei from the ductal
cells. Because all ductal cells had IND of < 1.5 times the
IND of lymphocyte nuclei, this value was used as the cut off
point for classifying tumour tissue as aneuploid.
DNA ploidy measured by flow cytometry classified 46
tumours as diploid and 55 as aneuploid, whereas by cell
image analysis 30 were diploid and 71 aneuploid (P<0.002.
Table II). There were 20 tumours with discrepancies between
the two methods. 18 of these were tumours with only one
peak in flow analysis but determined to be aneuploid with
image analysis. DNA content as measured by both methods
was significantly associated with histological grade (P<0.01),
but was not significantly related to menopausal status or
tumour size (Table III). C-erbB-2 expression was significantly
related to DNA ploidy by flow cytometry (P<0.01). but not
by cell image analysis (P = 0.13). Compared to those with
diploid tumours, patients with aneuploid tumours had signi-
ficantly earlier relapse and shorter survival after a minimum
of 10 years follow-up, as determined by log-rank test
(Figures 3 and 4). Histological grade, c-erbB-2 expression
and tumour size were also related to relapse and survival
(Table IV). Multivariate analysis showed DNA ploidv
measured by flow cytometry to be the only variable of
independent significance (P<0.02) for both relapse and
overall survival in the patients with node negative disease.
Ploidy measured by image analysis, tumour grade. c-erbB-2
expression and tumour size were not of independent signifi-
cance (Table IV). Table V indicates the increased sensitivity.
but loss of specificity. in correlation with survival that is
found when image analysis is used instead of flow cytometry
for determination of tumour ploidy. In detecting overall
survival after 10 years flow cytometry showed a sensitivity of
74.5% compared with that of image analysis (83%). How-
ever. flow cytometry showed better specificity (63%) than
image analysis (40.70o).
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Figure 3 The probability of relapse-free survival for patients with
diploid and aneuploid tumours. as determined by both image ana-
lvasis and flow cvtometr. --- Image analysis (P<0.003):
Flow cvtometrs (P=0.0002).
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The prognostic significance of DNA content in patients with
node negative breast cancer has been studied using flow
cvtometry. but the results have not been uniform (Clark et
al.. 1989: Muss et al.. 1989: Yuan et al.. 1991). In the present
Table II DNA ploidy measured by flow cytometry and image
analysis
Flow cytometr (n = 101) Cell image scan (n = 101)
Diploid (30) Aneuploid (71)
Diploid (46) 28 18
Aneuploid (55) 2 53
P = 0.0017 (Wilcoxon matched pairs test).
Table III The relationship between DNA ploidv and vanrables
.4neuploid Diploid P value
Variables Af(I f2) Ml Af2, UI (.Mf2
Menopausal St.
Premenopausal 14 (19) 18 (13)
Postmenopausal 41 (52) 28 (17) 0.15 (0.10)
B + R grade
1 + 20 (25) 29 (24)
3 33 (42) 12 ( 3) <0.01 (<0.01)
c-erbB-2
Positive 19 (20) 5 ( 4)
Negative 34 (47) 36 (23) <0.01 (0.13)
Tumour size
T, -25 (35) 28 (18)
T. 26 (32) 17 (11) 0.14 (0.25)
Ml = flow cytometry analysis: M2 = cell image analysis.
Figure 4 The probabilit)v of over-all survival for patients with
dipoid and aneuploid tumours, as determined by both image analysis
and flow cvtomerr. --- Image analvsis (P<0.005): Flow
cvtometrv (P = 0.0002).
study the DNA content of tumours from 101 breast cancer
patients with node negative disease was determined by flow
cytometry and cell image analysis. In keeping with other
reports. we found that the flow cytometric analysis demon-
strated a higher proportion of diploid tumours (46%) than
that obtained by image analysis (30%). Of the discrepancies.
90% (18 samples) were tumours classified as diploid by flow
cytometry but considered as aneuploid by image analysis.
Because flow cytometry assays the relative number of cells in
different populations. the resolution of normal diploid from
abnormal aneuploid populations by flow cytometric analysis
depends not only on the amount of overlap of the two
distributions but also on the clear presence of a significant
proportion of both normal and abnormal cells. There are
therefore three possible explanations for flow cytometry fail-
ing to detect an aneuploid population: (a) a wide coefficient
of variation of the diploid peak in flow cytometry might
mask an aneuploid population (cf. McFadden et al.. 1990):
(b) the aneuploid population might be low in proportion to
the number of normal cells and or at the tetraploid position
and therefore could be missed or misinterpreted as an in-
creased G, + M peak by flow cytometry (Bauer et al.. 1990):
or (c) if normal cells are low in proportion to the number of
tumour cells and therefore do not form an indentifiable peak
in the flow histogram. the aneuploid population might be
misinterpreted as normal. It is worth mentioning that in
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Table IV Urnivariate and multivariate analysis of factors related to
disease-free and overall survival
U'nivariate Multivariate
DFS OS DFS OS
Variables P P P P
DNA ploidy (flow) 0.0002a .00002a <0.Oa <002a
DNA ploidy (cell image) 0.003a 0.005a 0.06 0.15
B + R grade 0.05a 0.016a ns ns
c-erbB-2 expression 0002a 0.003a ns ns
Tumour size 0.036a 0.026a ns ns
aStatistically significant. DFS = disease free survival; OS = overall
survival.
Table V Specificity and sensitiVity of flow and image analysis in
detecting overall survival
Flow Image
Diploid Aneuploid Diploid Aneuploid
Alive 34 20 22 32
Dead 12 35 8 39
Sensitivity = 35 47 = 74.5% o. SensitiVity = 39 47 = 83.0° o.
Specificity = 34 54 =63.0°%o. Specificitv =2" 54 = 40.7°o.
McFadden's study (1990). where it was suggested that a Wide
CV may mask near-diploid DNA aneuploidy. the mean of
the DNA index measured by image analysis on tumours
having a wide flow histogram CV (5.35%-11.9%) was on
average 1.38 times that of the normal tissue. An aneuploid
population with 1.38 times the normal DNA content would
not normally be hidden by a diploid peak even if it had a CV
as wide as 12%. We do not feel that the lack of sensitivity in
the flow cytometric method can be completely explained by
overlap of peaks with wide CVs. Because of the lack of an
appropriate external standard for DNA histogram analysis
on flow cytometry of fixed tissue, a single peak is conven-
tionally classified as diploid. However, this peak could be
composed of diploid nuclei or aneuploid nuclei or both.
We found that some samples with only one peak and a
narrow CV (<4%) by flow cytometry had a high IND ratio
and were thus determined to be aneuploid by image analysis.
It was noted that the number of normal cells in these sections
was low. The normal nuclei therefore may not have formed a
significant peak in the DNA histogram from flow cytometry:
the single peak present may have been composed of abnor-
mal nuclei only. Similarly. if the abnormal nuclei were few in
number relative to normal cells. this sample could also be
misclassified by flow cytometry. Using image analysis, in this
study the operator measured the IND directly on selected
tumour cells and on normal ly-mphocytes from slides of the
paraffin sections: as long as both types of cells were present.
classification by image analysis was therefore not affected by
the relative proportions of the two types of cells. Our results
suggest that image analysis techniques can provide more
objective information of the DNA content of tumour cells by
direct measurement of integrated nuclear DNA density on
selected cells and by using normal lymphocytes in the same
section as controls. Image analysis, in particular. allows
measurements of samples with either few lymphocytes or few
tumour cells. The disadvantage of image analysis is that the
operator must be familiar with cell morphology and also that
the results may be affected by the selection of nuclei for
measurement and by the criteria adopted to classify samples
as diploid or aneuploid. In the present study. we used the
ratio 1.5 as a cutoff point based on the results comparing
normal breast ductal cells to normal lymphocytes.
DNA ploidy measured by both methods was significantly
associated with histological grade. which in itself was a good
predictor of clinical outcome on univariate analysis. DNA
aneuploidy was strongly associated with poorly differentiated
tumours. which is in agreement with other studies (Feichter
et al., 1988; Kallioniemi et al.. 1987: O'Reilly et al.. 1990).
There was positive correlation between nuclear size and IND:
since nuclear size is an important parameter in histological
grading. the relationship between DNA ploidy and histo-
logical grade is to be expected. Although the DNA ploidy
results measured by the two methods were significantly differ-
ent. the outcome for patients in this study was significantly
related to tumour ploidy as determined by either method.
Patients with aneuploid tumours by both methods had short-
er disease free and overall survival by univariate analysis
after a minimum 10 years follow-up. To examine the relative
importance of DNA ploidy as a prognostic factor in patients
with node negative breast cancer. the independent prognostic
significance of these results must be assessed by multivariate
analysis. DNA ploidy measured by flow cytometry was of
independent value when related to prognosis. but DNA con-
tent measured by image analysis was not. Therefore. the
increased sensitiVity of image analysis for detecting aneuploid
cells was not reflected in increased clinical value.
With the advent of the National Breast Screening Pro-
gramme the number of women presenting with node negative
breast cancer will increase, and identification of women with
potentially poor outcome from within such good prognostic
groups is difficult. Tumour ploidy. measured by either flow
cytometry or image analysis. may play an important role in
this task.
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